Lars L Thomsen Selected Research

Iron Deficiencies

1/2022	Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery.
1/2021	Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
11/2016	High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
1/2016	A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
9/2015	A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
1/2015	A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease.
9/2011	Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars L Thomsen Research Topics

Disease

11	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 09/2011
7	Iron Deficiencies 01/2022 - 09/2011
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2016
4	Chronic Renal Insufficiency 01/2021 - 09/2011
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2016 - 01/2012
3	Hypophosphatemia 01/2022 - 04/2016
3	Fatigue 01/2019 - 04/2016
3	Anemia 04/2016 - 09/2011
2	Hypersensitivity (Allergy) 01/2022 - 01/2019
1	Headache (Headaches) 01/2020
1	Nausea 01/2020
1	Postpartum Hemorrhage 01/2019
1	Chronic Disease (Chronic Diseases) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Neoplasms (Cancer) 04/2016
1	Wounds and Injuries (Trauma) 12/2014
1	Hyperhidrosis 12/2014

Drug/Important Bio-Agent (IBA)

15	iron isomaltoside 1000IBA 01/2022 - 09/2011
15	IronIBA 01/2022 - 09/2011
6	Saccharated Ferric Oxide (Venofer)FDA Link 01/2022 - 01/2017
6	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2015
5	ferric derisomaltoseIBA 01/2022 - 01/2020
3	Phosphates (Orthophosphate)IBA 01/2020 - 04/2016
2	Sulfates (Sulfates, Inorganic)IBA 04/2016 - 12/2013
1	ferric carboxymaltoseIBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	MineralsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	Fibroblast Growth Factor-23IBA 11/2016
1	HematinicsIBA 04/2016

Therapy/Procedure

1	Bariatric Surgery 01/2022
1	Drug Therapy (Chemotherapy) 04/2016
1	Therapeutics 01/2016
1	Sympathectomy (Sympathectomies) 12/2014
1	Surgical Instruments (Clip) 12/2014
1	Injections 01/2012